nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymetazoline—HTR2A—enteric nervous system—Crohn's disease	0.0506	0.276	CbGeAlD
Oxymetazoline—HTR2A—myenteric nerve plexus—Crohn's disease	0.0384	0.209	CbGeAlD
Oxymetazoline—NISCH—smooth muscle tissue—Crohn's disease	0.0119	0.0647	CbGeAlD
Oxymetazoline—NISCH—mammalian vulva—Crohn's disease	0.0107	0.0583	CbGeAlD
Oxymetazoline—ADRA1D—epithelium—Crohn's disease	0.0103	0.0561	CbGeAlD
Oxymetazoline—HTR2B—smooth muscle tissue—Crohn's disease	0.00689	0.0376	CbGeAlD
Oxymetazoline—HTR2B—skin of body—Crohn's disease	0.0068	0.0371	CbGeAlD
Oxymetazoline—ADRA1A—epithelium—Crohn's disease	0.00591	0.0322	CbGeAlD
Oxymetazoline—HTR2B—digestive system—Crohn's disease	0.00544	0.0297	CbGeAlD
Oxymetazoline—NISCH—lymph node—Crohn's disease	0.00536	0.0292	CbGeAlD
Oxymetazoline—ADRA2C—mammalian vulva—Crohn's disease	0.00488	0.0266	CbGeAlD
Oxymetazoline—ADRA1A—lymphoid tissue—Crohn's disease	0.00455	0.0248	CbGeAlD
Oxymetazoline—ADRA2A—mammalian vulva—Crohn's disease	0.0039	0.0212	CbGeAlD
Oxymetazoline—HTR2A—epithelium—Crohn's disease	0.00382	0.0208	CbGeAlD
Oxymetazoline—HTR2A—smooth muscle tissue—Crohn's disease	0.00368	0.0201	CbGeAlD
Oxymetazoline—HTR2B—lymph node—Crohn's disease	0.00311	0.0169	CbGeAlD
Oxymetazoline—HTR2A—digestive system—Crohn's disease	0.00291	0.0158	CbGeAlD
Oxymetazoline—ADRA2C—lymph node—Crohn's disease	0.00245	0.0133	CbGeAlD
Oxymetazoline—ADRA2A—lymph node—Crohn's disease	0.00195	0.0106	CbGeAlD
Oxymetazoline—ADRA1D—Signaling Pathways—PTGER4—Crohn's disease	0.000265	0.000324	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—RIPK2—Crohn's disease	0.000265	0.000324	CbGpPWpGaD
Oxymetazoline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000264	0.000324	CbGpPWpGaD
Oxymetazoline—ADRA2C—Hemostasis—JAK2—Crohn's disease	0.000264	0.000323	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—IL3—Crohn's disease	0.000263	0.000323	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—IL3—Crohn's disease	0.000261	0.00032	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CCR6—Crohn's disease	0.000261	0.000319	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—IL3—Crohn's disease	0.000258	0.000316	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—UBE2D1—Crohn's disease	0.000256	0.000314	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—IL2RA—Crohn's disease	0.000255	0.000313	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—RASGRP1—Crohn's disease	0.000255	0.000312	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CCR6—Crohn's disease	0.000254	0.000311	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000253	0.00031	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CCR6—Crohn's disease	0.00025	0.000306	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—RASGRP1—Crohn's disease	0.00025	0.000306	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—RIPK2—Crohn's disease	0.000249	0.000304	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—IL2RA—Crohn's disease	0.000248	0.000304	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—RBX1—Crohn's disease	0.000246	0.000301	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—IL2RA—Crohn's disease	0.000244	0.000299	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—IL3—Crohn's disease	0.000242	0.000297	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—IL2RA—Crohn's disease	0.000241	0.000296	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR ligand binding—CXCL8—Crohn's disease	0.000241	0.000295	CbGpPWpGaD
Oxymetazoline—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.00024	0.000294	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—PTGER4—Crohn's disease	0.000239	0.000293	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—UBE2D1—Crohn's disease	0.000238	0.000292	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—RBX1—Crohn's disease	0.000236	0.000289	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR ligand binding—CXCL8—Crohn's disease	0.000236	0.000289	CbGpPWpGaD
Oxymetazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000235	0.000287	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—RASGRP1—Crohn's disease	0.000234	0.000287	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—IL2RA—Crohn's disease	0.000232	0.000284	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR downstream signaling—JAK2—Crohn's disease	0.000231	0.000283	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—RIPK2—Crohn's disease	0.000231	0.000283	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—SOCS1—Crohn's disease	0.000231	0.000283	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—ALB—Crohn's disease	0.000231	0.000283	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—PTGER4—Crohn's disease	0.00023	0.000281	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—RBX1—Crohn's disease	0.000229	0.000281	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—JAK2—Crohn's disease	0.000226	0.000277	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CCR6—Crohn's disease	0.000226	0.000277	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—SOCS1—Crohn's disease	0.000226	0.000277	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—RBX1—Crohn's disease	0.000226	0.000276	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—IL2RA—Crohn's disease	0.000226	0.000276	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—IL3—Crohn's disease	0.000226	0.000276	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—PTGER4—Crohn's disease	0.000223	0.000273	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—IL2RA—Crohn's disease	0.000222	0.000272	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000222	0.000272	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CCR6—Crohn's disease	0.000222	0.000272	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—TYK2—Crohn's disease	0.00022	0.00027	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—PTGER4—Crohn's disease	0.00022	0.000269	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR ligand binding—CXCL8—Crohn's disease	0.000219	0.000268	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—RASGRP1—Crohn's disease	0.000218	0.000267	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000217	0.000266	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—TYK2—Crohn's disease	0.000216	0.000264	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—UBE2D1—Crohn's disease	0.000215	0.000264	CbGpPWpGaD
Oxymetazoline—ADRA2A—Hemostasis—JAK2—Crohn's disease	0.000215	0.000263	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—JAK2—Crohn's disease	0.000213	0.00026	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—SOCS1—Crohn's disease	0.000212	0.00026	CbGpPWpGaD
Oxymetazoline—HTR1D—GPCR downstream signaling—CXCL8—Crohn's disease	0.000211	0.000258	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—JAK2—Crohn's disease	0.00021	0.000257	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—RIPK2—Crohn's disease	0.000209	0.000256	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—UBE2D1—Crohn's disease	0.000207	0.000253	CbGpPWpGaD
Oxymetazoline—HTR1B—GPCR downstream signaling—CXCL8—Crohn's disease	0.000207	0.000253	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CCR6—Crohn's disease	0.000206	0.000252	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—JAK2—Crohn's disease	0.000206	0.000252	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—RBX1—Crohn's disease	0.000205	0.000251	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—IL3—Crohn's disease	0.000204	0.000249	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—TYK2—Crohn's disease	0.000202	0.000248	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000202	0.000247	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—IL2RA—Crohn's disease	0.000201	0.000247	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—UBE2D1—Crohn's disease	0.000201	0.000246	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—RBX1—Crohn's disease	0.0002	0.000246	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—RIPK2—Crohn's disease	0.0002	0.000246	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—PTGER4—Crohn's disease	0.000199	0.000244	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—SMAD3—Crohn's disease	0.000199	0.000244	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—UBE2D1—Crohn's disease	0.000198	0.000242	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—JAK2—Crohn's disease	0.000198	0.000242	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—SOCS1—Crohn's disease	0.000198	0.000242	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—IL2RA—Crohn's disease	0.000197	0.000241	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—RASGRP1—Crohn's disease	0.000197	0.000241	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IL3—Crohn's disease	0.000196	0.000239	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—PTGER4—Crohn's disease	0.000195	0.000239	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—SMAD3—Crohn's disease	0.000195	0.000239	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—RIPK2—Crohn's disease	0.000195	0.000239	CbGpPWpGaD
Oxymetazoline—HTR2B—GPCR downstream signaling—CXCL8—Crohn's disease	0.000194	0.000238	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—JAK2—Crohn's disease	0.000193	0.000237	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—RIPK2—Crohn's disease	0.000192	0.000235	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—TYK2—Crohn's disease	0.000192	0.000235	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—CXCL8—Crohn's disease	0.000192	0.000235	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IL3—Crohn's disease	0.00019	0.000233	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—RASGRP1—Crohn's disease	0.000189	0.000232	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—TYK2—Crohn's disease	0.000188	0.000231	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—CXCL8—Crohn's disease	0.000188	0.00023	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IL3—Crohn's disease	0.000187	0.000229	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—RBX1—Crohn's disease	0.000186	0.000228	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—IL2RA—Crohn's disease	0.000185	0.000226	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—RASGRP1—Crohn's disease	0.000184	0.000225	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—SMAD3—Crohn's disease	0.000183	0.000225	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—IL2RA—Crohn's disease	0.000183	0.000224	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—JAK2—Crohn's disease	0.000183	0.000224	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—PTGER4—Crohn's disease	0.000181	0.000222	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—RASGRP1—Crohn's disease	0.000181	0.000222	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—IL2RA—Crohn's disease	0.000181	0.000221	CbGpPWpGaD
Oxymetazoline—ADRA1D—GPCR downstream signaling—CXCL8—Crohn's disease	0.000181	0.000221	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—JAK2—Crohn's disease	0.00018	0.00022	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	0.00018	0.00022	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—JAK2—Crohn's disease	0.000179	0.000219	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—SOCS1—Crohn's disease	0.000178	0.000218	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—CXCL8—Crohn's disease	0.000176	0.000216	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	0.000176	0.000215	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	0.000174	0.000213	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—JAK2—Crohn's disease	0.000172	0.00021	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—SOCS1—Crohn's disease	0.000171	0.00021	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—SMAD3—Crohn's disease	0.000171	0.000209	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	0.00017	0.000209	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—TYK2—Crohn's disease	0.00017	0.000208	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IL3—Crohn's disease	0.00017	0.000208	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—IL2RA—Crohn's disease	0.00017	0.000208	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—CXCL8—Crohn's disease	0.000167	0.000205	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—JAK2—Crohn's disease	0.000167	0.000204	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—SOCS1—Crohn's disease	0.000167	0.000204	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IL3—Crohn's disease	0.000166	0.000204	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—JAK2—Crohn's disease	0.000164	0.000201	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	0.000164	0.000201	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—CXCL8—Crohn's disease	0.000164	0.000201	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—SOCS1—Crohn's disease	0.000164	0.000201	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	0.000163	0.0002	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	0.000163	0.0002	CbGpPWpGaD
Oxymetazoline—ADRA2B—GPCR downstream signaling—CXCL8—Crohn's disease	0.000163	0.0002	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—JAK2—Crohn's disease	0.000162	0.000199	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	0.000161	0.000197	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—TYK2—Crohn's disease	0.000159	0.000195	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling by GPCR—IL6—Crohn's disease	0.000159	0.000195	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	0.000158	0.000194	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—IL2RA—Crohn's disease	0.000158	0.000193	CbGpPWpGaD
Oxymetazoline—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	0.000157	0.000192	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—TYK2—Crohn's disease	0.000156	0.000192	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	0.000156	0.000191	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IL3—Crohn's disease	0.000154	0.000189	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—SMAD3—Crohn's disease	0.000154	0.000189	CbGpPWpGaD
Oxymetazoline—ADRA2C—GPCR downstream signaling—CXCL8—Crohn's disease	0.000152	0.000187	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—JAK2—Crohn's disease	0.000152	0.000186	CbGpPWpGaD
Oxymetazoline—ADRA1B—GPCR downstream signaling—CXCL8—Crohn's disease	0.00015	0.000184	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	0.000149	0.000183	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—JAK2—Crohn's disease	0.000149	0.000183	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	0.000149	0.000183	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	0.000149	0.000182	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—CXCL8—Crohn's disease	0.000148	0.000181	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	0.000148	0.000181	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	0.000146	0.000179	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	0.000146	0.000178	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—SMAD3—Crohn's disease	0.000144	0.000176	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—IL2RA—Crohn's disease	0.000143	0.000175	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	0.000142	0.000174	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	0.000142	0.000174	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—SMAD3—Crohn's disease	0.000142	0.000173	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	0.000139	0.00017	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—CXCL8—Crohn's disease	0.000138	0.000169	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	0.000137	0.000168	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—CXCL8—Crohn's disease	0.000136	0.000167	CbGpPWpGaD
Oxymetazoline—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000136	0.000167	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	0.000136	0.000166	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	0.000135	0.000166	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	0.000135	0.000166	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—STAT3—Crohn's disease	0.000134	0.000164	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IL2RA—Crohn's disease	0.000133	0.000163	CbGpPWpGaD
Oxymetazoline—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000133	0.000163	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	0.000133	0.000162	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IL2RA—Crohn's disease	0.000131	0.000161	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—TYK2—Crohn's disease	0.00013	0.000159	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	0.000129	0.000158	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	0.000128	0.000157	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—TYK2—Crohn's disease	0.000127	0.000156	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	0.000126	0.000154	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—JAK2—Crohn's disease	0.000124	0.000152	CbGpPWpGaD
Oxymetazoline—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000124	0.000152	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	0.000124	0.000151	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	0.000123	0.000151	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—JAK2—Crohn's disease	0.000121	0.000149	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	0.000121	0.000148	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—TYK2—Crohn's disease	0.00012	0.000146	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	0.000119	0.000146	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	0.000117	0.000143	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	0.000116	0.000143	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—ALB—Crohn's disease	0.000115	0.000141	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—JAK2—Crohn's disease	0.000114	0.00014	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—CXCL8—Crohn's disease	0.000113	0.000139	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	0.000112	0.000138	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—TYK2—Crohn's disease	0.000111	0.000136	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—CXCL8—Crohn's disease	0.000111	0.000136	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	0.000108	0.000133	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling by GPCR—IL6—Crohn's disease	0.000108	0.000132	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—JAK2—Crohn's disease	0.000106	0.00013	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling by GPCR—IL6—Crohn's disease	0.000105	0.000129	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—CXCL8—Crohn's disease	0.000104	0.000128	CbGpPWpGaD
Oxymetazoline—ADRA2C—Metabolism—PTGS2—Crohn's disease	0.000101	0.000123	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—TYK2—Crohn's disease	0.0001	0.000123	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling by GPCR—IL6—Crohn's disease	9.9e-05	0.000121	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—CXCL8—Crohn's disease	9.69e-05	0.000119	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—TYK2—Crohn's disease	9.65e-05	0.000118	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—JAK2—Crohn's disease	9.59e-05	0.000117	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—TYK2—Crohn's disease	9.39e-05	0.000115	CbGpPWpGaD
Oxymetazoline—HTR1E—Signaling Pathways—IL6—Crohn's disease	9.38e-05	0.000115	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—ALB—Crohn's disease	9.36e-05	0.000115	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—TYK2—Crohn's disease	9.24e-05	0.000113	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling by GPCR—IL6—Crohn's disease	9.21e-05	0.000113	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—JAK2—Crohn's disease	9.21e-05	0.000113	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—STAT3—Crohn's disease	9.11e-05	0.000112	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—JAK2—Crohn's disease	8.95e-05	0.00011	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—STAT3—Crohn's disease	8.92e-05	0.000109	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—JAK2—Crohn's disease	8.81e-05	0.000108	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—CXCL8—Crohn's disease	8.75e-05	0.000107	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	8.4e-05	0.000103	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—TYK2—Crohn's disease	8.38e-05	0.000103	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—STAT3—Crohn's disease	8.38e-05	0.000103	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling by GPCR—IL6—Crohn's disease	8.32e-05	0.000102	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	8.21e-05	0.0001	CbGpPWpGaD
Oxymetazoline—ADRA2A—Metabolism—PTGS2—Crohn's disease	8.19e-05	0.0001	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—CXCL8—Crohn's disease	8.17e-05	0.0001	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—CXCL8—Crohn's disease	8.04e-05	9.85e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—JAK2—Crohn's disease	7.99e-05	9.79e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling by GPCR—IL6—Crohn's disease	7.99e-05	9.78e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	7.83e-05	9.59e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—STAT3—Crohn's disease	7.79e-05	9.54e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling by GPCR—IL6—Crohn's disease	7.77e-05	9.52e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling by GPCR—IL6—Crohn's disease	7.65e-05	9.37e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	7.62e-05	9.34e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	7.3e-05	8.94e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	7.27e-05	8.91e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	7.14e-05	8.75e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—STAT3—Crohn's disease	7.04e-05	8.62e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling by GPCR—IL6—Crohn's disease	6.94e-05	8.5e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	6.79e-05	8.32e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—STAT3—Crohn's disease	6.76e-05	8.27e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	6.64e-05	8.13e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—STAT3—Crohn's disease	6.57e-05	8.05e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—STAT3—Crohn's disease	6.47e-05	7.92e-05	CbGpPWpGaD
Oxymetazoline—HTR1D—Signaling Pathways—IL6—Crohn's disease	6.36e-05	7.79e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	6.31e-05	7.73e-05	CbGpPWpGaD
Oxymetazoline—HTR1B—Signaling Pathways—IL6—Crohn's disease	6.23e-05	7.63e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—STAT3—Crohn's disease	5.87e-05	7.19e-05	CbGpPWpGaD
Oxymetazoline—HTR2B—Signaling Pathways—IL6—Crohn's disease	5.85e-05	7.16e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	5.75e-05	7.04e-05	CbGpPWpGaD
Oxymetazoline—ADRA1D—Signaling Pathways—IL6—Crohn's disease	5.44e-05	6.67e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	5.34e-05	6.54e-05	CbGpPWpGaD
Oxymetazoline—ADRA2B—Signaling Pathways—IL6—Crohn's disease	4.91e-05	6.02e-05	CbGpPWpGaD
Oxymetazoline—HTR2C—Signaling Pathways—IL6—Crohn's disease	4.72e-05	5.78e-05	CbGpPWpGaD
Oxymetazoline—ADRA2C—Signaling Pathways—IL6—Crohn's disease	4.59e-05	5.62e-05	CbGpPWpGaD
Oxymetazoline—ADRA1B—Signaling Pathways—IL6—Crohn's disease	4.52e-05	5.53e-05	CbGpPWpGaD
Oxymetazoline—HTR2A—Signaling Pathways—IL6—Crohn's disease	4.1e-05	5.02e-05	CbGpPWpGaD
Oxymetazoline—ADRA1A—Signaling Pathways—IL6—Crohn's disease	4.01e-05	4.91e-05	CbGpPWpGaD
Oxymetazoline—ADRA2A—Signaling Pathways—IL6—Crohn's disease	3.73e-05	4.57e-05	CbGpPWpGaD
